We are live on
!
Find out more
iBio
IBIO
IBIO
21 hedge funds and large institutions have $345K invested in iBio in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
9,550% more call options, than puts
Call options by funds: $193K | Put options by funds: $2K
28% more capital invested
Capital invested by funds: $270K → $345K (+$75.2K)
17.7% more ownership
Funds ownership: 0.16% → 17.86% (+18%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
19% less funds holding
Funds holding: 26 → 21 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
7
Closed
10
Calls
$193K
Puts
$2K
Net Calls
+$191K
Net Calls Change
+$75K
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$772K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$111K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$83K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$74.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$20.9K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$76.2K |
| 2 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$47K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$34.2K |
| 4 |
HF
HRT Financial
New York
|
-$19K |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.6K |
